Bharat Immunologicals (India) Valuation

BIBCL -- India Stock  

INR 8.70  0.30  3.33%

Bharat Immunologicals shows prevailing Real Value of 7.8393 per share. The current price of the firm is 8.7. At this time the firm appears to be overvalued. Macroaxis approximates value of Bharat Immunologicals from analyzing the firm fundamentals such as Return On Equity of (10.18)% and Profit Margin of (12.30)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Horizon     30 Days    Login   to change
Bharat Immunologicals Biologicals Corp Ltd is rated second in price to earning category among related companies. It is rated below average in beta category among related companies . The ratio of Price to Earning to Beta for Bharat Immunologicals Biologicals Corp Ltd is about  611.35 

Current Market Valuation

Bharat Immunologicals Valuation Boundaries

Overvalued
March 21, 2019
8.70
Market Value
7.84
Real Value
Target Odds
Odds Odds
17.35
Upside
Bharat Immunologicals is relatively risky asset. Calculation of real value of Bharat Immunologicals is based on 2 months time horizon. Increasing Bharat Immunologicals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Search macroaxis.com